Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.
about
Role of lung surfactant in phagocytic clearance of apoptotic cells by macrophages in ratsLipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture systemLipid microspherule-associated acute monarticular arthritisOcular toxicity in low-dose tamoxifen: a prospective studyVortex keratopathy in a patient receiving vandetanib for non-small cell lung cancer.Identification of drugs inducing phospholipidosis by novel in vitro dataTamoxifen retinopathy.Drug hepatotoxicity.Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.Amiodarone-induced lung toxicity. In vitro evidence for the direct toxicity of the drug.Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.Molecular parameters involved in aminoglycoside nephrotoxicity.Interaction with the hERG channel and cytotoxicity of amiodarone and amiodarone analogues.Pathology and Neurotoxicity in Dogs after Repeat Dose Exposure to a Serotonin 5-HT1B InhibitorAcid phospholipase A1 in liver--a brief survey.Mechanisms of aminoglycoside nephrotoxicity.Primary pulmonary responses to toxic agents.Pulmonary and generalized lysosomal storage induced by amphiphilic drugs.Studies on the fate of pulmonary surfactant in the lung.Early changes in chlorphentermine myopathy of rat studied by freeze fracturing.Effects of chloroquine and Nifedipine on the phospholipid content and enzyme activity in the subcellular fraction of ischemic rat liver.A comparative study of the effect of pigment on drug toxicity in human choroidal melanocytes and retinal pigment epithelial cells.Experimental lipidosis of the inner ear.Effect of chloroquine on oestrus cycle and ovulation in cyclic rats.Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse.Iprindole reverses the lamellar body deficiency of cultured L-2 cells. Possible implications in the reversal of surfactant deficiency.Chronic gentamicin nephrotoxicity. Continued tubular injury with preserved glomerular filtration functionPulmonary retention of iodobenzyl-propanediamine in humans. Effect of cigarette smoking.The role of lipophilicity in the extrahepatic disposition of aminostilbene derivatives following administration to rat.Coadministration of Atorvastatin and Amiodarone Increases the Risk of Pulmonary Fibrosis in Rats.[Drug-induced phospholipidosis. An example of the use of NMR spectroscopy in pharmacologic research]Amiodarone-induced angioedema.Dose- and Time-dependency of the Toxicity and Pharmacokinetic Profiles of Bedaquiline and Its N-desmethyl Metabolite in Dogs.A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red.
P2860
Q23917073-675FF93C-8B1C-4FE8-8498-8E77A1618543Q28276749-FDEBCE0D-0879-46BD-9FA7-F77B2E75E761Q28304036-D0B3F7A2-E641-4F38-ADE6-117D6E84F733Q28372746-C9EC7DC6-4406-4012-9C92-506356C2B567Q30473842-5A4F2001-6465-46E0-A522-94CD6D78C1AFQ30560958-EF65ED48-BE66-431C-A3F2-810F1C259879Q33640989-321317EC-F0F4-471C-AA4C-7853C6A0A6B0Q34512476-94CA2B5D-0F37-472C-8E92-A14E1D367E35Q34736225-6DA40F47-6BBD-478E-9BBB-1209CC1ABCE6Q35835289-29AC9926-E146-4F78-995F-D0317B34E70FQ35947304-C6AD10C8-73BA-483E-9D03-8C1FB34DC976Q36285892-EE9F4AA8-3A5D-4F12-B680-03EB4C9EBFBCQ36629997-A99AB04F-F00E-4731-8894-57C5D9AF06DEQ36720602-6F25946E-FD49-4207-A7D6-294101D561A9Q36964943-2C721E8C-1F60-49D4-B4B6-D7A0CC04DB4CQ37723945-802E15EE-790D-44FE-A21E-E9BF4D93515EQ38610979-C8ED3A4E-54FD-4DB3-8155-72E11FE48EE3Q38618223-DBF1C412-4761-4F41-BE5B-8D9826FC8076Q39624412-245C8D9A-DE04-4AAD-B215-502EC0557E81Q40180023-39AF9C0B-2C12-4722-AECB-DABE47210B2EQ40208216-98C1EBC8-ED0C-485A-BF0C-2142C3DD849DQ40471679-3276847E-1409-4499-B329-41873718EA10Q41923493-DE4FB116-F6E7-4837-A752-657F61F1D25DQ41924345-910A5E0C-418A-4FF4-B11B-6245610D0493Q41927218-6BBFE85E-4B52-4BCA-9175-8E42FCD3DADEQ41940635-E5002547-6241-4DB7-AE12-B98E9F72A98BQ41944039-73BF77AF-D760-4E2C-B6EC-40C036FC4843Q41978782-D0D8EFEB-EB6A-4EBA-A0D8-8BB47D6C9B00Q41984540-E536787D-01B5-4FF6-A2BF-8A74B6ACA9B1Q42210713-C8F4213C-9F3E-4973-AB42-F96BA86AE5CEQ42273513-39E26A62-B935-4ABF-85DB-1163D22CB4B6Q42756330-498501EF-5759-4734-BDB9-7797B46064A6Q43475856-B46D04B5-F4C5-4343-A94F-6C46FFC0C4CBQ43512088-F47D57DB-74D9-436F-A443-8125E8600CC6Q50507423-67126B87-2168-44F2-B6CA-8F296A450435Q50749605-2AB5C868-DE1B-4FC6-8528-D67B33BF1A11
P2860
Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
Drug-induced phospholipidoses. ...... iphilic drug chlorphentermine.
@en
type
label
Drug-induced phospholipidoses. ...... iphilic drug chlorphentermine.
@en
prefLabel
Drug-induced phospholipidoses. ...... iphilic drug chlorphentermine.
@en
P2093
P2860
P1476
Drug-induced phospholipidoses. ...... iphilic drug chlorphentermine.
@en
P2093
Lüllmann H
Lüllmann-Rauch R
Wassermann O
P2860
P304
P356
10.1080/10408447509164014
P577
1975-11-01T00:00:00Z